Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Pharmaceutical combination for use in glycemic control in diabetes type 2 patients|
|Abstract:||The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.|
|Inventor(s):||Niemoeller; Elisabeth (Frankfurt am Main, DE), Muehlen-Bartmer; Isabel (Frankfurt am Main, DE), Silvestre; Louise (Paris, FR), Boka; Gabor (Paris, FR), Miossec; Patrick (Paris, FR)|
|Assignee:||Sanofi-Aventis Deutschland GMBH (Frankfurt am Main, DE)|
1. A method for improvement of glycemic control in a patient having diabetes type 2, comprising administering to the patient a therapeutically effective amount of the
pharmaceutical combination comprising: (a) desPro.sup.36Exendin-4(1-39)-Lys.sub.6-NH.sub.2 and/or a pharmaceutically acceptable salt thereof, and (b) a glitazone and/or a pharmaceutically acceptable salt thereof; and wherein the patient has a
haemoglobin A1c (HbA.sub.1c) value of at least 8% and a fasting plasma glucose of at least 9 mmol/L when treated with glitazone alone.
2. The method of claim 1, wherein the patient is an adult.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.